- Home
- FENC vs TCMD Comparison
FENC vs TCMD Comparison
Compare FENC & TCMD Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
Company Overview
Basic Information| Metric | FENC | TCMD |
|---|---|---|
| Founded | 1996 | 1995 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Biotechnology: Biological Products (No Diagnostic Substances) | Medical/Dental Instruments |
| Sector | Health Care | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 263.3M | 300.1M |
| IPO Year | 2010 | 2016 |
Fundamental Metrics
Financial Performance| Metric | FENC | TCMD |
|---|---|---|
| Price | $8.03 | $29.16 |
| Analyst Decision | Strong Buy | Strong Buy |
| Analyst Count | 3 | 4 |
| Target Price | $15.00 | ★ $36.00 |
| AVG Volume (30 Days) | 108.5K | ★ 399.6K |
| Earning Date | 01-01-0001 | 05-19-2026 |
| Dividend Yield | N/A | N/A |
| EPS Growth | ★ 96.67 | 17.14 |
| EPS | N/A | ★ 0.82 |
| Revenue | ★ $47,538,000.00 | N/A |
| Revenue This Year | N/A | $7.70 |
| Revenue Next Year | $70.78 | $8.79 |
| P/E Ratio | ★ N/A | $35.70 |
| Revenue Growth | ★ 123.69 | N/A |
| 52 Week Low | $4.68 | $8.61 |
| 52 Week High | $9.92 | $37.77 |
Technical Indicators
Market Signals| Indicator | FENC | TCMD |
|---|---|---|
| Relative Strength Index (RSI) | 44.70 | 51.61 |
| Support Level | $7.45 | $29.11 |
| Resistance Level | $8.09 | $30.92 |
| Average True Range (ATR) | 0.45 | 1.79 |
| MACD | -0.06 | 0.12 |
| Stochastic Oscillator | 28.83 | 26.76 |
Price Performance
Historical ComparisonAbout FENC Fennec Pharmaceuticals Inc.
Fennec Pharmaceuticals Inc is a commercial-stage biopharmaceutical company. Its product candidate is PEDMARK which is sodium thiosulfate in a novel formulation for the prevention of cisplatin-induced hearing loss, or ototoxicity in children. The company principally operates in the United States.
About TCMD Tactile Systems Technology Inc.
Tactile Systems Technology Inc is a medical technology company. The company is engaged in developing and providing medical devices for the treatment of chronic diseases. The firm's proprietary platform flexitouch system provides a home-based solution for lymphedema patients. The entire system is another home solution for patients with chronic swelling and actitouch system for chronic venous insufficiency patients that may be worn throughout the day.